Hongene Biotech shows advanced oligonucleotide CDMO capabilities via support of SiranBio’s dual-target siRNA programme: Singapore Saturday, May 9, 2026, 16:00 Hrs [IST] Hongene ...

Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymat ...

Research and Development expenses for the first quarter of 2026 were $11.4 million compared to $12.9 million in the first quarter of 2025. The decrease was primarily due to lower allocable costs, ...

Regulatory Engagement -- Codexis is preparing a briefing for its next FDA interaction as part of the Emerging Technologies Program and is assembling materials for Advanced Manufacturing Technologies ...

Large-scale manufacturing of oligonucleotides could become more environmentally friendly if the biotech industry can overcome the challenges of a promising technique for synthesizing them. That’s ...

Peptides and oligonucleotides, often grouped together as TIDES, are increasingly seen as powerful therapeutic tools. 2 Their high specificity, tunable biological activity, and ability to modulate ...

Delpacibart etedesiran led mostly to mild to moderate adverse events in a phase I/II trial of myotonic dystrophy type 1, but two serious events occurred. The antibody-oligonucleotide conjugate reduced ...

Myotonic dystrophy type 1 is a rare, dominantly inherited, progressive, disabling, neuromuscular disease that leads to decreased life expectancy and has no approved therapies. The disease is caused by ...

High school science misses a lot of the science researchers actually work with. For example, you learn that there are three states of matter—solid, liquid, and gas—but in advanced physics, things get ...

When ice melts into water, it happens quickly, with the transition from solid to liquid being immediate. However, very thin materials do not adhere to these rules. Instead, an unusual state between ...